AVITA Medical (RCEL) Depreciation and Depletion (2019 - 2025)
AVITA Medical (RCEL) posted Depreciation and Depletion of $400000.0 for Q4 2025, down 4.99% on a QoQ basis from $421000.0 in Q3 2025, and up 17.99% year-over-year from $339000.0 in Q4 2024.
AVITA Medical (RCEL) Depreciation and Depletion (2019 - 2025) Analysis & Trends
AVITA Medical's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $400000.0 for Q4 2025.
- Quarterly Depreciation and Depletion rose 17.99% year-over-year to $400000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 60.6% YoY) and the FY2025 annual result came in at $1.6 million, up 60.0% from the prior year.
- Depreciation and Depletion was $400000.0 for Q4 2025 at AVITA Medical, down from $421000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $429000.0 in Q3 2021 and bottomed at $122000.0 in Q4 2022.
- A 5-year average of $246222.2 and a median of $186500.0 in 2024 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion jumped 128.19% — and 2022, when it sank 69.7%.
- AVITA Medical's Depreciation and Depletion stood at $429000.0 in 2021, then sank by 71.56% to $122000.0 in 2022, then surged by 45.9% to $178000.0 in 2023, then surged by 90.45% to $339000.0 in 2024, then grew by 17.99% to $400000.0 in 2025.
- Business Quant data shows RCEL's Depreciation and Depletion at $400000.0 in Q4 2025, $421000.0 in Q3 2025, and $400000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 421,000.00 |
| Sep 30, 2025 | 421,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 385,000.00 |
| Mar 31, 2025 | 385,000.00 |
| Dec 31, 2024 | 339,000.00 |
| Dec 31, 2024 | 339,000.00 |
| Sep 30, 2024 | 288,000.00 |
| Sep 30, 2024 | 288,000.00 |
| Jun 30, 2024 | 187,000.00 |
| Jun 30, 2024 | 187,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 178,000.00 |
| Dec 31, 2023 | 178,000.00 |
| Sep 30, 2023 | 156,000.00 |
| Sep 30, 2023 | 156,000.00 |